Drug class
Angiotensin-converting enzyme (ACE) inhibitor; antihypertensive prodrug
Mechanism of action
Imidapril is hydrolysed to the active metabolite imidaprilat, which competitively inhibits angiotensin-converting enzyme. This reduces angiotensin II formation and aldosterone secretion, lowers peripheral vascular resistance and blood pressure, and reduces sodium and water retention.
General use cases
- Treatment of essential hypertension.
- Use in selected patients with chronic heart failure or diabetic nephropathy has been described in clinical studies and depends on local product authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
